CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

Clinical trial NCT04088864 · COMPLETED

Trial details

NCT number: NCT04088864
Sponsor: Kara Lynn Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma Acute Lymphoblastic Leukemia, Pediatric Lymphoma

Start date: 2020-01-10
Primary completion: 2021-11-08
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.